ConductScience.org, home

Paper42983151PubMed

H3K18 lactylation promotes osteosarcoma cell proliferation and migration through transcriptional activation of m6A reader YTHDF2.

Peng M and 6 others. In Vitro Cell Dev Biol Anim, 2026.

Cite this record

ConductScience Library. H3K18 lactylation promotes osteosarcoma cell proliferation and migration through transcriptional activation of m6A reader YTHDF2. Papers, record 42983151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42983151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
H3K18 lactylation promotes osteosarcoma cell proliferation and migration through transcriptional activation of m6A reader YTHDF2.
Journal
In Vitro Cell Dev Biol Anim
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-11-04

Source PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Peng MMao
2Jing JJiajia
3Tian RRenwei
4Zhang CChunJuan
5Peng LLiyun
6Wang XXiaoqing
7Ma XXuhua

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133734139Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020.Chin Med J (Engl)2021https://conductscience.org/library/papers/33734139PubMed
236614339Correction: Chen et al. The Chemerin/CMKLR1 Axis Is Involved in the Recruitment of Microglia to Aβ Deposition through p38 MAPK Pathway. Int. J. Mol. Sci. 2022, 23, 9041.Int J Mol Sci2022https://conductscience.org/library/papers/36614339PubMed
338033505Long non-coding RNA PRR7-AS1 promotes osteosarcoma progression via binding RNF2 to transcriptionally suppress MTUS1.Front Oncol2023https://conductscience.org/library/papers/38033505PubMed
432829036Clinical efficiency of epigenetic drugs therapy in bone malignancies.Bone2021https://conductscience.org/library/papers/32829036PubMed
534216543Inhibition of YTHDF2 triggers proteotoxic cell death in MYC-driven breast cancer.Mol Cell2021https://conductscience.org/library/papers/34216543PubMed
636856188Lactylation: novel epigenetic regulatory and therapeutic opportunities.Am J Physiol Endocrinol Metab2023https://conductscience.org/library/papers/36856188PubMed
741940424Ginkgolide A Suppresses Osteosarcoma Proliferation and Activates the Apoptotic Pathway by Targeting the KAT2A-H3K18la Lactylation Axis.Anticancer Agents Med Chem2026https://conductscience.org/library/papers/41940424PubMed
834131316Advancing therapy for osteosarcoma.Nat Rev Clin Oncol2021https://conductscience.org/library/papers/34131316PubMed
917320500Epigenetics: a landscape takes shape.Cell2007https://conductscience.org/library/papers/17320500PubMed
1035732125Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-β signaling in regulatory T cells.Cell Rep2022https://conductscience.org/library/papers/35732125PubMed
1140683951MARCH8/NSUN6/ROS-mediated DNA damage positive feedback loop regulates cisplatin resistance in osteosarcoma.Cell Death Differ2025https://conductscience.org/library/papers/40683951PubMed
1242245633Lactylation-driven metabolic reprogramming promotes osteosarcoma malignancy via HDGF-mediated proliferation and immune modulation.Front Immunol2026https://conductscience.org/library/papers/42245633PubMed
1339662272m6A methylation modification: Potential pathways to suppress osteosarcoma metastasis.Int Immunopharmacol2025https://conductscience.org/library/papers/39662272PubMed
1438512058Dux activates metabolism-lactylation-MET network during early iPSC reprogramming with Brg1 as the histone lactylation reader.Nucleic Acids Res2024https://conductscience.org/library/papers/38512058PubMed
1534150616Lactate Modulates Cellular Metabolism Through Histone Lactylation-Mediated Gene Expression in Non-Small Cell Lung Cancer.Front Oncol2021https://conductscience.org/library/papers/34150616PubMed
1640868849Epigenetic Modifications in Osteosarcoma: Mechanisms and Therapeutic Strategies.Life (Basel)2025https://conductscience.org/library/papers/40868849PubMed
1733121495YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.Mol Cancer2020https://conductscience.org/library/papers/33121495PubMed
1837615625Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer.Autophagy2024https://conductscience.org/library/papers/37615625PubMed
1935765275KLF5-induced miR-487a augments the progression of osteosarcoma cells by targeting NKX3-1 in vitro.Oncol Lett2022https://conductscience.org/library/papers/35765275PubMed
2036621008Lactate, histone lactylation and cancer hallmarks.Expert Rev Mol Med2023https://conductscience.org/library/papers/36621008PubMed

See all 42 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42983151

GET https://conductscience.org/api/papers/v1/42983151/references?page=2